(Image source=COVID-19 Vaccine Clinical Trial Participation Campaign Site)

(Image source=COVID-19 Vaccine Clinical Trial Participation Campaign Site)

View original image

[Asia Economy Reporter Lee Chun-hee] The National Clinical Trial Support Foundation announced on the 17th that it has launched a ‘COVID-19 Vaccine Clinical Trial Participation’ campaign site to assist in recruiting participants for domestic COVID-19 vaccine clinical trials.


This COVID-19 vaccine clinical trial participation campaign site was established to spread national consensus on vaccine clinical trial participation and contribute to forming a positive perception, thereby helping to recruit clinical trial participants. On the site, visitors can view a support video for COVID-19 vaccine clinical trial participation (100 scenes featuring national representatives), access information related to clinical trials, check benefits of participating in vaccine clinical trials (to be updated later), and easily apply for a clinical trial participation intention form through the ‘Clinical Trial Participation’ section.


The support video features interviews encouraging participation from various celebrities, including Bae Byung-jun, chairman of the Clinical Trial Support Foundation and the first person to submit a clinical trial participation intention form as a participant in the domestic vaccine clinical trial, as well as actor Kim Ji-seok and others, along with messages encouraging participation from the general public.


Additionally, a ‘Hall of Fame’ corner has been set up to display electronic nameplates expressing gratitude to actual clinical trial participants and applicants of the clinical trial participation intention form. As of this date, electronic nameplates of about 3,000 applicants have been exhibited, and the site plans to update regularly as more applicants are recruited.



Chairman Bae Byung-jun stated, "To complete the development of the domestic COVID-19 vaccine, the interest and participation of the public in vaccine clinical trials are needed more than ever," adding, "We will continue to promote various publicity activities that can elicit national consensus on COVID-19 vaccine clinical trials."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing